MAVIS edition 94

Marketing Authorisations Veterinary Information Service (MAVIS) edition 94


MAVIS edition 94

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


  • VMD corporate branding change
  • VMD on GOV.UK
  • Improving our guidance on veterinary medicines
  • Products containing controlled drugs
  • Mock-ups: Changes to administrative details
  • Applications for biopharmaceutical products or products containing a Persistent Bio Accumulative and Toxic (PBT) substance
  • Veterinary medicines product supply problems
  • Top ten Imported Veterinary Medicines Quarterly Report from 1 January to 27 March 2015
  • Seizure notices
  • Improvement notices
  • Pharmacovigilance quarterly report
  • Pharmacovigilance periodic safety update reports (PSURs) - Clamping down on non-compliance
  • Defra Antimicrobial Resistance Co-ordination (DARC) group update
  • Heads of Medicines Agencies - Veterinary (HMA-V) action plan on antimicrobial issues
  • UK antimicrobial resistance strategy
  • Sales data report and antibiotic resistance surveillance report
  • Meetings of the VPC
  • Residues Controls and Monitoring (Statutory and Non-Statutory)
  • Staff Changes
  • Marketing Authorisations
  • Annex 1 - Quarterly Reporting Against VMD Published Standards for Licensing Work 2014/15
  • Annex 2 – Organogram for May 2015

MAVIS is designed to provide you with the best available information on the work of the Veterinary Medicines Directorate (VMD), our plans and results, as well as general developments on the controls of animal medicines. MAVIS is published quarterly and copies can be accessed from

Published 29 April 2015